Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xoma Corp
(NQ:
XOMA
)
25.41
+0.05 (+0.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Xoma Corp
< Previous
1
2
Next >
XOMA Stock Earnings: XOMA Misses EPS, Misses Revenue for Q4 2023
March 08, 2024
XOMA stock results show that XOMA missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Recap: XOMA Q4 Earnings
March 08, 2024
Via
Benzinga
Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma
February 16, 2024
XOMA acquires Kinnate Biopharma for $2.3352 per share, with potential additional cash. The acquisition is expected to close in April 2024.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
August 28, 2023
During Monday, 102 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 27, 2023
During Thursday, 56 stocks hit new 52-week lows.
Via
Benzinga
XOMA's Return On Capital Employed Insights
May 24, 2023
Via
Benzinga
XOMA Earnings Perspective: Return On Capital Employed
March 15, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 01, 2023
On Friday, 57 companies reached new 52-week lows.
Via
Benzinga
Arimoclomol and Aldoxorubicin Acquisition to Bolster XOMA's Revenue Growth: Analyst
June 22, 2023
Earlier today, XOMA Corporation (NASDAQ: XOMA) acquired the royalty and milestone rights associated with two assets from LadRx Corporation: arimoclomol for Niemann-Pick disease type C, and...
Via
Benzinga
Recap: XOMA Q1 Earnings
May 09, 2023
XOMA (NASDAQ:XOMA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by 96.0%,...
Via
Benzinga
XOMA's Return On Capital Employed Insights
November 24, 2022
Via
Benzinga
Starbucks And 3 Other Stock Insiders Are Buying
September 19, 2022
Although US stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
Recap: XOMA Q4 Earnings
March 08, 2022
XOMA (NASDAQ:XOMA) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
July 26, 2023
Wednesday saw 59 companies set new 52-week lows.
Via
Benzinga
XOMA: Q1 Earnings Insights
May 09, 2023
XOMA (NASDAQ:XOMA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:30 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by 96.0%,...
Via
Benzinga
XOMA: Q3 Earnings Insights
November 03, 2022
XOMA (NASDAQ:XOMA) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:45 AM. Here's what investors need to know about the announcement. Earnings XOMA missed estimated earnings by...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 08, 2022
On Thursday, 168 companies reached new 52-week lows.
Via
Benzinga
XOMA Earnings Perspective: Return On Capital Employed
May 27, 2022
Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q1 sales of $3.11 million. Earnings fell to a loss of $2.28 million, resulting in a 107.64% decrease from last quarter. In Q4, XOMA earned $29.84 million,...
Via
Benzinga
XOMA's Return On Capital Employed Insights
March 10, 2022
According to Benzinga Pro, during Q4, XOMA (NASDAQ:XOMA) earned $29.84 million, a 772.77% increase from the preceding quarter. XOMA also posted a total of $35.94 million in sales...
Via
Benzinga
50 Biggest Movers From Yesterday
January 06, 2022
Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares surged 63.7% to settle at $2.21 on Wednesday after the company announced that in preclinical studies its lead...
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 04, 2022
During Wednesday's trading, 435 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 05, 2022
Gainers Lixte Biotech Holdings (NASDAQ:LIXT) stock increased by 70.4% to $2.3 during Wednesday's regular session. Trading volume for this security as of 12:31 EST is...
Via
Benzinga
XOMA's Return On Capital Employed Overview
November 08, 2021
Benzinga Pro data, XOMA (NASDAQ:XOMA) reported Q3 sales of $940.00 thousand. Earnings fell to a loss of $3.35 million, resulting in a 9.17% decrease from last quarter. In Q2,...
Via
Benzinga
XOMA's Return On Capital Employed Overview
September 08, 2021
According to Benzinga Pro data, during Q2, XOMA (NASDAQ:XOMA) posted sales of $901.00 thousand. Earnings were up 52.33%, but XOMA still reported an overall loss of $3.06 million....
Via
Benzinga
Why Did Wedbush Downgrade Xoma?
September 07, 2021
Wedbush has cut XOMA Corporation (NASDAQ: XOMA) to neutral from outperform and lowered its price target to $22 from $41. Analyst Liana Moussatos notes ...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021
September 07, 2021
Upgrades BMO Capital upgraded the previous rating for BRP Inc (NASDAQ:
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 03, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP
Via
Benzinga
Recap: XOMA Q2 Earnings
August 05, 2021
Shares of XOMA (NASDAQ:XOMA) were flat after the company reported Q2 results. Quarterly Results Earnings per share increased 12.12% over the past year to ($0.29), which beat...
Via
Benzinga
Why XOMA Stock Is Trading Higher Wednesday?
July 28, 2021
XOMA Corporation (NASDAQ: XOMA) stock is trading higher during the morning session on robust volume after the FDA granted an Orphan drug tag to NIS793 for...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
July 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.